LLY Looks 26.9% Undervalued on GF Value™

gurufocus.com · 2026-09-11

On September 11, 2026, Eli Lilly and Company (NYSE: LLY) completed its acquisition of AtaiBeckley, a clinical-stage biopharmaceutical company specializing in ne

Read the full story at gurufocus.com →